Robert Roskoski, J. (2023). Rule of five violations among the FDA-approved small molecule protein kinase inhibitors. Elsevier.
Chicago Style (17th ed.) CitationRobert Roskoski, Jr. Rule of Five Violations Among the FDA-approved Small Molecule Protein Kinase Inhibitors. Elsevier, 2023.
MLA (9th ed.) CitationRobert Roskoski, Jr. Rule of Five Violations Among the FDA-approved Small Molecule Protein Kinase Inhibitors. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.